ATE118546T1 - Mutanten des transformierenden affenwachstumsfaktors beta-1. - Google Patents

Mutanten des transformierenden affenwachstumsfaktors beta-1.

Info

Publication number
ATE118546T1
ATE118546T1 AT89403294T AT89403294T ATE118546T1 AT E118546 T1 ATE118546 T1 AT E118546T1 AT 89403294 T AT89403294 T AT 89403294T AT 89403294 T AT89403294 T AT 89403294T AT E118546 T1 ATE118546 T1 AT E118546T1
Authority
AT
Austria
Prior art keywords
beta
tgf
cells
precursor
growth factor
Prior art date
Application number
AT89403294T
Other languages
English (en)
Inventor
Anthony F Purchio
Larry Gentry
Daniel Twardzik
Amy M Brunner
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Application granted granted Critical
Publication of ATE118546T1 publication Critical patent/ATE118546T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Control Of Eletrric Generators (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89403294T 1988-12-16 1989-11-28 Mutanten des transformierenden affenwachstumsfaktors beta-1. ATE118546T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28591788A 1988-12-16 1988-12-16
US35017189A 1989-04-17 1989-04-17
US35372889A 1989-05-17 1989-05-17

Publications (1)

Publication Number Publication Date
ATE118546T1 true ATE118546T1 (de) 1995-03-15

Family

ID=27403570

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89403294T ATE118546T1 (de) 1988-12-16 1989-11-28 Mutanten des transformierenden affenwachstumsfaktors beta-1.

Country Status (16)

Country Link
EP (1) EP0373994B1 (de)
JP (1) JPH03130089A (de)
KR (1) KR900009985A (de)
CN (1) CN1044125A (de)
AT (1) ATE118546T1 (de)
AU (1) AU638952B2 (de)
CA (1) CA2003886A1 (de)
DE (1) DE68921167T2 (de)
DK (1) DK638989A (de)
ES (1) ES2070924T3 (de)
FI (1) FI895730A0 (de)
IE (1) IE67811B1 (de)
IL (1) IL92489A0 (de)
NO (1) NO179676C (de)
NZ (1) NZ231581A (de)
PT (1) PT92454B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293785A3 (de) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Klonierung und Expression von transformierendem Affenwachstumsfaktor-SS 1
US5304541A (en) * 1988-12-15 1994-04-19 Bristol-Myers Squibb Company Methods using novel chimeric transforming growth factor-β1/β2
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
GB0100551D0 (en) * 2001-01-09 2001-02-21 Queen Mary & Westfield College Protein
US7141392B2 (en) 2001-01-09 2006-11-28 Queen Mary And Westfield College Latent fusion protein
EP1279740A1 (de) * 2001-07-26 2003-01-29 Vrije Universiteit Brussel Von Adeno-assoziertem Virus abstammender Vektor zur Gentherapy
WO2005068499A1 (en) * 2004-01-06 2005-07-28 The Government Of The United States As Representedby The Secretary, Department Of Health & Human Services Compositions and methods for the high efficiency expression of the transforming growth factor-beta supergene family
WO2012055541A1 (en) * 2010-10-25 2012-05-03 Bavarian Nordic A/S Tgf-beta in the development of conventional dendritic cells and uses thereof
CN104311631A (zh) * 2014-09-28 2015-01-28 苏州普罗达生物科技有限公司 转化生长因子β1激动剂多肽及其制备方法、应用
CN104211778A (zh) * 2014-09-28 2014-12-17 苏州普罗达生物科技有限公司 一种转化生长因子β1激动剂多肽及其制备方法、应用
RU2652312C2 (ru) * 2016-01-20 2018-04-25 Селл энд Джин Терапи Лтд Линейка биологически активных генно-терапевтических субстанций на основе гена tgfb1 для коррекции патологических состояний клеток органов и тканей и органов и тканей человека, способ получения и использования

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
EP0293785A3 (de) * 1987-05-29 1990-05-02 Oncogen Limited Partnership Klonierung und Expression von transformierendem Affenwachstumsfaktor-SS 1
CA2005120A1 (en) * 1988-12-15 1990-06-15 Anthony F. Purchio Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
FI901920A0 (fi) * 1989-04-20 1990-04-17 Lubrizol Corp Foerfaranden foer minskning av friktionen mellan i foerhaollande till varandra glidande komponenter genom anvaendning av metallkarboxylater.

Also Published As

Publication number Publication date
DK638989D0 (da) 1989-12-15
NO894759D0 (no) 1989-11-29
DE68921167T2 (de) 1995-06-01
JPH03130089A (ja) 1991-06-03
NO179676B (no) 1996-08-19
FI895730A0 (fi) 1989-11-29
AU638952B2 (en) 1993-07-15
AU4588289A (en) 1990-06-21
IE893779L (en) 1990-06-16
EP0373994A1 (de) 1990-06-20
DK638989A (da) 1990-06-17
PT92454A (pt) 1990-06-29
CA2003886A1 (en) 1990-06-16
ES2070924T3 (es) 1995-06-16
NO894759L (no) 1990-06-18
EP0373994B1 (de) 1995-02-15
PT92454B (pt) 1995-07-18
NO179676C (no) 1996-11-27
IE67811B1 (en) 1996-05-01
NZ231581A (en) 1993-01-27
CN1044125A (zh) 1990-07-25
DE68921167D1 (de) 1995-03-23
KR900009985A (ko) 1990-07-06
IL92489A0 (en) 1990-08-31

Similar Documents

Publication Publication Date Title
EP0293785A3 (de) Klonierung und Expression von transformierendem Affenwachstumsfaktor-SS 1
DE68921167T2 (de) Mutanten des transformierenden Affenwachstumsfaktors beta-1.
US4835260A (en) Erythropoietin composition
ES2266159T3 (es) Mejora de la galactosilacion de glicoproteinas recombinantes.
ATE127518T1 (de) Mikrobisch-produziertes rinderwachstumshormon und dessen verwendung.
ATE483817T1 (de) Adeno-assoziiertes virus mit invertierten terminalen 'repeats' als promoter
ATE267215T1 (de) Heterodimäre fusionsproteine zur verwendung für gezielte immuntherapie und allgemeine immunerregung
EP1670918B1 (de) Leitsequenzen zur verwendung bei der produktion von proteinen
US20040115775A1 (en) Homogeneity and secretion of recombinant proteins in mammalian systems
KR900009983A (ko) Tgf-베타1/베타2 : 새로운 망상 변형 성장인자-베타
JP2007300935A (ja) タンパク質を産生する能力を有し且つ無グルタミン培地中で成長する能力を有するグルタミン栄養要求性ヒト細胞
BR9905867A (pt) Linhagem celular produtora de eritropoietina humana recombinante e a eritropoietina humana recombinante produzida por esta célula
KR100496001B1 (ko) 폴리펩티드의제조방법
Chung et al. Development of recombinant Chinese hamster ovary cell lines producing human thrombopoietin or its analog
KR102559048B1 (ko) Cho 세포 유래 단백질 분비 인자 및 이를 포함하는 발현 벡터
GB2314332A (en) Gene expression in mammalian cells
EP0282512A4 (de) Stabilisierung von messenger-rns in tierischen zellen.
EP0603393A1 (de) Rekombinantes humanes interleukin-6 mit homogenem n-terminus und seine herstellung
ES2255177T3 (es) Fabricacion de proteinas mutadas humanas en celulas humanas por medio de la recombinacion homologa.
CA2295310A1 (en) Method for increasing secretion of proteins in eukaryotic host cells
JPS63196268A (ja) 無血清培地で継代増殖可能な形質転換細胞、その育種方法およびその細胞による蛋白質の生産方法
Chen et al. Regulated secretion of prolactin by the mouse insulinoma cell line βTC-3
KR960034404A (ko) 조직형 플라스미노젠 액티베이터 단백질을 발현하는 형질전환된 동물 세포주

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee